ImmunoRx Pharma, Inc. — Form D
ImmunoRx Pharma, Inc. of WILMINGTON, DE, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-17. The offering totals $25.4M, of which $2.7M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-02-17
- Form: D
- Accession: 0001845314-21-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $25.4M
- Amount sold: $2.7M
- Remaining: $22.8M
- Investors: 2
- Date of first sale: 2020-11-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-389613
Issuer
- Name: ImmunoRx Pharma, Inc.
- CIK: 0001845314
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1000 N. WEST ST., SUITE 1200, WILMINGTON, DE, 19801
- Phone: 6493324417
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Alexandre Lebeaut | Director | Southlake, TX |
| Marc Riviere | Director | Roseville, MN |
| Philippe Tessier | Director | Lewis, A8 |
| Mark Cipriano | Executive Officer | Wilmington, DE |
| Caroline Fortier | Executive Officer | Wilmington, DE |
More